Global Hematology Instruments and Reagents Market to Reach US$5.6 Billion by 2017, According to a New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Hematology Instruments and Reagents market. The global market for hematology instruments and reagents is forecast to reach US$5.6 billion by the year 2017, driven primarily by the aging population, discovery of new diseases, replacement needs of existing equipment with automated systems, and expanding application of flow cytometry techniques. Additionally, the healthcare reforms being undertaken across various regions is expected to significantly impact the demand for hematology Instruments and reagents in the upcoming years.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Hematology Instruments and Reagents: A Global Strategic Business Report

San Jose, California (PRWEB) April 20, 2012

Follow us on LinkedIn – Over the years, hematology instruments and reagents have become an indispensable diagnostic tool, and continue to maintain strong position in the global healthcare industry. Presently, automated hematology systems play a vital role in transfusion medicine, and facilitate screening of blood donors as well as quality control of blood products. The recent years also witnessed the emergence of novel tests for CHr, CSF, CD61, and CD64. In the upcoming years, sales of hematology reagents are expected to increase rapidly. Furthermore, increasing lab automation, along with the significance of accreditations, is expected to propel the demand even further. Other prospective growth drivers include increasing medical tourism, rising number of insured individuals, and more job prospects stressing on pre-employment testing. Additionally, global healthcare diagnostic testing industry, including hematology, promises significant growth potential, backed by the healthcare reforms being undertaken across various regions in developed and emerging markets, such as India and China.

Hematology analyzers represent the leading segment within the hematology instruments market. Demand for hematology analyzers is influenced by the development of alternative technologies, such as POC instruments and integrated analyzers, advancements in product automation, and highly streamlined laboratory processes. The market is also influenced by the shortage of skilled personnel in clinical labs, cost control pressures, error reduction issues, and low revenue contribution from reagents and consumables. Companies are investing large amounts on product developments, and are offering more sophisticated, user friendly, accurate, and efficient systems that meet the requirements of hospital and clinical laboratories. Cell analyzers presently available for lab purpose are multi-channeled, as they analyze various hematology measurements utilizing diverse techniques.

The United States leads the global Hematology Instruments and Reagents market. Replacement demand for hematology analyzers in the US has been largely hit by laboratory consolidation, and increase in the number of group purchasing organizations. Besides this, testing volumes have contracted due to the imposition of new standards. The US healthcare market had earlier witnessed a surge in the number of physician office laboratories where physicians conduct in-house tests. However, due to the strict adherence to regulatory guidelines, number of such laboratories has dropped subsequently which resulted in the reduced demand for low volume analyzers. Growth in demand for hematology instruments and reagents is expected to emanate from Asia-Pacific, Latin America, and other emerging markets. In-vitro diagnostic markets of Brazil, China, and India are registering significant growth, owing to the increasing population, economic development, increased healthcare spending, and higher affordability for private medical care. These three markets are expected to be the key growth engines for in-vitro diagnostics products, including hematology instruments and reagents, backed by the strong technical capabilities harbored by these countries.

Hematology analyzers represents the leading segment within the hematology/coagulation instruments market, as stated by the new market research report on Hematology Instruments and Reagents. Present day hematology analyzers are technologically advanced, as compared to the traditional systems that were developed twenty years back. Companies are investing large amounts on product developments, and are offering more sophisticated, user friendly, accurate, and efficient systems that meet the requirements of hospital and clinical laboratories. Flow cytometry techniques are widely prevalent in advanced world. However, opportunities exist in developing countries where cytometry and image analysis are still emerging.

The global market for hematology instruments clearly belongs to specialized players. Competition in the market is centered upon several factors, including price, product innovations, service, distribution, and promotion strategies. Hence, the scenario essentially calls for significant investment in research and product innovations, and strategic alliances to maintain competitive advantage. Sysmex, Beckman Coulter, and Abbott Laboratories are the global majors in the hematology market. Apart from these three major companies, the global hematology market comprises several small companies. Going forwards, the market is likely to see the entry of several new companies, owing to the reforms being undertaken by the developed and developing regions, and the low entry barriers. The market, resultantly, would see increased competition due to the numerous product introductions by several new companies.

Major players profiled in the report include Abbott Diagnostics Inc., Beckman Coulter Inc., Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Diagnostica Stago, Horiba Ltd., Instrumentation Laboratory Inc., Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Sysmex Corp., among others.

The research report titled "Hematology Instruments and Reagents: A Global Strategic Business Report" announced by Global Industry Analysts Inc., provides a comprehensive review of the Hematology Instruments and Reagents market, current market trends, key growth drivers, new product innovations/launches, recent industry activity, and profiles of major/niche global market participants. The report provides annual sales estimates and projections for the global Hematology Instruments and Reagents market for the years 2009 through 2017 for regions, including US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Key segments analyzed include Hematology/Coagulation Instruments (Hematology Analyzers, Hematology Flow Cytometers, Coagulation Analyzers, Hemoglobinometers, Slide Stainers, Hematology Centrifuges, and Hematology Vials), and Hematology/Coagulation Reagents (Flow Cytometry Reagents, Coagulation Reagents, Hematology Reagents, Immuno-Hematology Reagents, Control Plasmas, and Hematology Stains). The study also provides historic data for an insight into market evolution over the period 2003 through 2008.

For more details about this comprehensive market research report, please visit –
http://www.strategyr.com/Hematology_Instruments_And_Reagents_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/


Contact

Attachments